Your browser doesn't support javascript.
loading
Author Correction: Anti-GD2 CAR-NKT cells in relapsed or refractory neuroblastoma: updated phase 1 trial interim results.
Heczey, Andras; Xu, Xin; Courtney, Amy N; Tian, Gengwen; Barragan, Gabriel A; Guo, Linjie; Amador, Claudia Martinez; Ghatwai, Nisha; Rathi, Purva; Wood, Michael S; Li, Yanchuan; Zhang, Chunchao; Demberg, Thorsten; Di Pierro, Erica J; Sher, Andrew C; Zhang, Huimin; Mehta, Birju; Thakkar, Sachin G; Grilley, Bambi; Wang, Tao; Weiss, Brian D; Montalbano, Antonino; Subramaniam, Meena; Xu, Chenling; Sachar, Chirag; Wells, Daniel K; Dotti, Gianpietro; Metelitsa, Leonid S.
Afiliação
  • Heczey A; Department of Pediatrics, Center for Advanced Innate Cell Therapy, Baylor College of Medicine, Houston, TX, USA. heczey@bcm.edu.
  • Xu X; Department of Medicine, Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX, USA. heczey@bcm.edu.
  • Courtney AN; Department of Pediatrics, Center for Advanced Innate Cell Therapy, Baylor College of Medicine, Houston, TX, USA.
  • Tian G; Department of Pediatrics, Center for Advanced Innate Cell Therapy, Baylor College of Medicine, Houston, TX, USA.
  • Barragan GA; Department of Pediatrics, Center for Advanced Innate Cell Therapy, Baylor College of Medicine, Houston, TX, USA.
  • Guo L; Department of Pediatrics, Center for Advanced Innate Cell Therapy, Baylor College of Medicine, Houston, TX, USA.
  • Amador CM; Department of Pediatrics, Center for Advanced Innate Cell Therapy, Baylor College of Medicine, Houston, TX, USA.
  • Ghatwai N; Department of Pediatrics, Center for Advanced Innate Cell Therapy, Baylor College of Medicine, Houston, TX, USA.
  • Rathi P; Department of Pediatrics, Center for Advanced Innate Cell Therapy, Baylor College of Medicine, Houston, TX, USA.
  • Wood MS; Department of Pediatrics, Center for Advanced Innate Cell Therapy, Baylor College of Medicine, Houston, TX, USA.
  • Li Y; Department of Pediatrics, Center for Advanced Innate Cell Therapy, Baylor College of Medicine, Houston, TX, USA.
  • Zhang C; Department of Pediatrics, Center for Advanced Innate Cell Therapy, Baylor College of Medicine, Houston, TX, USA.
  • Demberg T; Department of Pediatrics, Center for Advanced Innate Cell Therapy, Baylor College of Medicine, Houston, TX, USA.
  • Di Pierro EJ; Department of Pediatrics, Center for Advanced Innate Cell Therapy, Baylor College of Medicine, Houston, TX, USA.
  • Sher AC; Department of Pediatrics, Center for Advanced Innate Cell Therapy, Baylor College of Medicine, Houston, TX, USA.
  • Zhang H; Department of Radiology, Texas Children's Hospital, Baylor College of Medicine, Houston, TX, USA.
  • Mehta B; Department of Medicine, Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX, USA.
  • Thakkar SG; Department of Medicine, Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX, USA.
  • Grilley B; Department of Medicine, Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX, USA.
  • Wang T; Department of Medicine, Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX, USA.
  • Weiss BD; Biostatistics and Data Management Resource, Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX, USA.
  • Montalbano A; Department of Pediatrics, Cincinnati Children's Hospital, Cincinnati, OH, USA.
  • Subramaniam M; Immunai, Inc., New York, NY, USA.
  • Xu C; Immunai, Inc., New York, NY, USA.
  • Sachar C; Immunai, Inc., New York, NY, USA.
  • Wells DK; Immunai, Inc., New York, NY, USA.
  • Dotti G; Immunai, Inc., New York, NY, USA.
  • Metelitsa LS; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Nat Med ; 30(4): 1210, 2024 Apr.
Article em En | MEDLINE | ID: mdl-38195754

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article